Evaluate Cognitive Function News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Cognitive Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Cognitive Function Today - Breaking & Trending Today

INmune Bio : Announces First Patient Dosed in Phase 2 XPro1595 Trial for Treatment of Neuroinflammation as a Cause of Alzheimer's disease - Form 8-K

Published: April 14, 2022

INmune Bio Announces First Patient Dosed in Phase 2 XPro1595 Trial for Treatment of Neuroinflammation as a Cause of Alzheimer's disease INmune Bio Plans to Enroll 201 Patients... | April 13, 2022

Source: marketscreener.com

Related Topics:

United StatesBoca RatonDavid MossInmune BioJason NelsonInmunebio IncGlobe Newswire Inmune Bio IncInmune Bio IncCompany Current Reports On FormDrug AdministrationCompany Quarterly Reports On FormCompany Annual Report On FormExchange CommissionBio Announces First Patient DosedBio PlansMonth StudyEvaluate Cognitive FunctionMild AlzheimerVice PresidentTumor Necrosis FactorDominant Negative Tumor Necrosis FactorMild Cognitive ImpairmentNatural Killer Cell Priming PlatformPrivate Securities Litigation Reform ActAnnual Report